Johnson & Johnson leads the way to a world without disease

Cat Oyler, Global Head of External Innovation Strategy and Operations at Johnson & Johnson (J&J), has an ambitious and compelling vision for the future of healthcare: a world without disease. She spoke to pharmaphorum as part of the latest in the eye-on-innovation series of articles. As one of the largest and most broadly-based healthcare companies in the world and with a heritage stretching back for over 130 years, Johnson & Johnson is well-positioned to lead this charge. With a diverse range of products including medical devices, pharmaceuticals, over-the-counter drugs and consumer health products, the company reaches out to millions of patients across the world.  But External Innovation Strategy Head Cat Oyler said in an interview with pharmaphorum that J&J’s ambitions extend far beyond the next set of quarterly results.